Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication

Xiao-Song Zhong; Maiko Matsushita; Jason Plotkin; Isabelle Rivière; Michel Sadelain

doi:10.1038/mt.2009.210

Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication

著者: Xiao-Song Zhong, Maiko Matsushita, Jason Plotkin, Isabelle Rivière, Michel Sadelain - Molecular Therapy 2009 被引用: 541

Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication | Litlas